A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons

A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
复制标题

DOI:
10.1038/sj.emboj.7600441
复制
发表时间:
2005-01-12
期刊:
影响因子:
11.4
通讯作者:
Pant, HC
Pant, HC
中科院分区:
生物学1区
文献类型:
--
作者:
Zheng, YL;Kesavapany, S;Pant, HC

文献摘要

被引文献

相似文献

淀粉样蛋白β (Abeta)肽的细胞外聚集和特定表位上tau蛋白的细胞内过度磷酸化是神经退行性疾病(如阿尔茨海默病(AD))的病理标志。当Cdk5与p25结合时,可磷酸化AD特异性磷酸化表位上的tau蛋白。p25是一种截断的激活因子,由暴露于β肽的生理Cdk5激活因子p35产生。我们发现Cdk5抑制肽(CIP)的神经元感染选择性地抑制p25/ Cdk5活性并抑制皮质神经元中异常的tau磷酸化。此外,与CIP共感染后,Abeta(1-42)-诱导的皮质神经元凋亡也减少。特别重要的是,我们发现CIP不会抑制内源性或转染的p35/ Cdk5活性,也不会抑制其他细胞周期蛋白依赖性激酶,如Cdc2, Cdk2, Cdk4和Cdk6。因此,这些结果提供了一种策略,可以解决并可能改善神经退行性疾病的病理,这些疾病可能是p25异常激活Cdk5的结果,而不影响正常的Cdk5活性。
The extracellular aggregation of amyloid beta (Abeta) peptides and the intracellular hyperphosphorylation of tau at specific epitopes are pathological hallmarks of neurodegenerative diseases such as Alzheimer's disease ( AD). Cdk5 phosphorylates tau at AD- specific phospho- epitopes when it associates with p25. p25 is a truncated activator, which is produced from the physiological Cdk5 activator p35 upon exposure to Abeta peptides. We show that neuronal infections with Cdk5 inhibitory peptide ( CIP) selectively inhibit p25/ Cdk5 activity and suppress the aberrant tau phosphorylation in cortical neurons. Furthermore, Abeta(1-42)- induced apoptosis of these cortical neurons was also reduced by coinfection with CIP. Of particular importance is our finding that CIP did not inhibit endogenous or transfected p35/ Cdk5 activity, nor did it inhibit the other cyclin- dependent kinases such as Cdc2, Cdk2, Cdk4 and Cdk6. These results, therefore, provide a strategy to address, and possibly ameliorate, the pathology of neurodegenerative diseases that may be a consequence of aberrant p25 activation of Cdk5, without affecting ' normal' Cdk5 activity.